Cargando…
Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone
An 85-year-old women with transthyretin cardiac amyloidosis presented with generalized weakness, elevated liver function test levels, and creatinine kinase consistent with rhabdomyolysis 1 week after starting tafamidis. She was already taking atorvastatin and amiodarone, raising the possibility of a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304530/ https://www.ncbi.nlm.nih.gov/pubmed/34317174 http://dx.doi.org/10.1016/j.jaccas.2020.09.037 |
_version_ | 1783727357936271360 |
---|---|
author | Laird, Jessica Falk, Rodney H. Coyle, Melissa Cuddy, Sarah A.M. |
author_facet | Laird, Jessica Falk, Rodney H. Coyle, Melissa Cuddy, Sarah A.M. |
author_sort | Laird, Jessica |
collection | PubMed |
description | An 85-year-old women with transthyretin cardiac amyloidosis presented with generalized weakness, elevated liver function test levels, and creatinine kinase consistent with rhabdomyolysis 1 week after starting tafamidis. She was already taking atorvastatin and amiodarone, raising the possibility of a drug–drug interaction inhibiting the breakdown and excretion of atorvastatin, causing drug-induced rhabdomyolysis. (Level of Difficulty: Intermediate.) |
format | Online Article Text |
id | pubmed-8304530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83045302021-07-26 Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone Laird, Jessica Falk, Rodney H. Coyle, Melissa Cuddy, Sarah A.M. JACC Case Rep Mini-Focus Issue: Heart Failure An 85-year-old women with transthyretin cardiac amyloidosis presented with generalized weakness, elevated liver function test levels, and creatinine kinase consistent with rhabdomyolysis 1 week after starting tafamidis. She was already taking atorvastatin and amiodarone, raising the possibility of a drug–drug interaction inhibiting the breakdown and excretion of atorvastatin, causing drug-induced rhabdomyolysis. (Level of Difficulty: Intermediate.) Elsevier 2020-12-02 /pmc/articles/PMC8304530/ /pubmed/34317174 http://dx.doi.org/10.1016/j.jaccas.2020.09.037 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mini-Focus Issue: Heart Failure Laird, Jessica Falk, Rodney H. Coyle, Melissa Cuddy, Sarah A.M. Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title | Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title_full | Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title_fullStr | Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title_full_unstemmed | Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title_short | Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone |
title_sort | rhabdomyolysis in the setting of concomitant use of tafamidis, atorvastatin, and amiodarone |
topic | Mini-Focus Issue: Heart Failure |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304530/ https://www.ncbi.nlm.nih.gov/pubmed/34317174 http://dx.doi.org/10.1016/j.jaccas.2020.09.037 |
work_keys_str_mv | AT lairdjessica rhabdomyolysisinthesettingofconcomitantuseoftafamidisatorvastatinandamiodarone AT falkrodneyh rhabdomyolysisinthesettingofconcomitantuseoftafamidisatorvastatinandamiodarone AT coylemelissa rhabdomyolysisinthesettingofconcomitantuseoftafamidisatorvastatinandamiodarone AT cuddysaraham rhabdomyolysisinthesettingofconcomitantuseoftafamidisatorvastatinandamiodarone |